Cdc50CRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。Cdc50遺伝子サイレンサーは、Cdc50 CRISPR/Cas9ノックアウトプラスミドとCdc50Double Nickaseプラスミドとして利用可能です。遺伝子活性化用のCdc50CRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
Cdc50 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Cdc50A CRISPR/Cas9 KOプラスミド (h) | sc-403231 | h | Gene Knockout | GFP | 0 | ||
Cdc50A HDRプラスミド (h) | sc-403231-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Cdc50A Double Nickaseプラスミド (h) | sc-403231-NIC | h | Gene Knockout | Puromycin | 0 | ||
Cdc50A Double Nickaseプラスミド (h2) | sc-403231-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Cdc50A CRISPR/Cas9 KOプラスミド (m) | sc-427588 | m | Gene Knockout | GFP | 0 | ||
Cdc50A HDRプラスミド (m) | sc-427588-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Cdc50A Double Nickaseプラスミド (m) | sc-427588-NIC | m | Gene Knockout | Puromycin | 0 | ||
Cdc50A Double Nickaseプラスミド (m2) | sc-427588-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Cdc50B CRISPR/Cas9 KOプラスミド (h) | sc-414823 | h | Gene Knockout | GFP | 0 | ||
Cdc50B HDRプラスミド (h) | sc-414823-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Cdc50B Double Nickaseプラスミド (h) | sc-414823-NIC | h | Gene Knockout | Puromycin | 0 | ||
Cdc50B Double Nickaseプラスミド (h2) | sc-414823-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Cdc50B CRISPR/Cas9 KOプラスミド (m) | sc-433617 | m | Gene Knockout | GFP | 0 | ||
Cdc50B HDRプラスミド (m) | sc-433617-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Cdc50B Double Nickaseプラスミド (m) | sc-433617-NIC | m | Gene Knockout | Puromycin | 0 | ||
Cdc50B Double Nickaseプラスミド (m2) | sc-433617-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Cdc50 CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Cdc50A CRISPR Activationプラスミド (h) | sc-403231-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50A CRISPR Activationプラスミド (h2) | sc-403231-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50A Lentiviral Activation Particles (h) | sc-403231-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50A Lentiviral Activation Particles (h2) | sc-403231-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50A CRISPR Activationプラスミド (m) | sc-427588-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50A CRISPR Activationプラスミド (m2) | sc-427588-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50A Lentiviral Activation Particles (m) | sc-427588-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50A Lentiviral Activation Particles (m2) | sc-427588-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50B CRISPR Activationプラスミド (h) | sc-414823-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50B CRISPR Activationプラスミド (h2) | sc-414823-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50B Lentiviral Activation Particles (h) | sc-414823-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50B Lentiviral Activation Particles (h2) | sc-414823-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50B CRISPR Activationプラスミド (m) | sc-433617-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50B CRISPR Activationプラスミド (m2) | sc-433617-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50B Lentiviral Activation Particles (m) | sc-433617-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc50B Lentiviral Activation Particles (m2) | sc-433617-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |